Both MedTech and pharmaceutical companies have relied on our analysis to make decisions on tapping into revenue pockets, entering new markets.
Our analysis involves extensive in-depth interviews with key stakeholders including physicians, purchasing managers, CEOs of hospitals and allied healthcare professionals. We also utilize our extensive industry network to gather insights from senior CXO-level industry professionals with deep experience in those markets.
|Client||Multi-billion Dollar pharmaceutical conglomerate looking to deepen presence in Europe|
|Situation||Client, a global player in oncology specialty pharmaceuticals, wanted to broaden its presence in Western Europe and to increase sales|
|Our approach||We mapped EU4+UK as priority markets and conducted deep dive into
We recommended a clear strategy per country along with prioritization. Our recommendations included resource allocation, budgets required, sales to be expected and 5 years business plan per country, along with list of top 10 target accounts per country
|Results||Client was successful in getting board approval for aggressive entry into Europe. In a span of two years following our engagement, client gained significant market share which led them to invest further by setting up a manufacturing facility in Germany to further grow their business in Europe|